Catalyst Wire Dossier Catalyst Wire Dossier

lidocaine 4% cream (LMX4)

lidocaine · Janssen-Ciseron or unspecified
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for lidocaine 4% cream (LMX4), covering 2022-12-28 to 2022-12-28. Get the full timeline:

Most recent: Clinical Trial Update: "Lidocaine 4% Cream (LMX4) vs Placebo for Pain Due to Lumbar Puncture in Infants 0-60 Days of Age." [Phase 4]

See pricing